References
- Marinho PM, Nascimento H, Romano A, Muccioli C, Belfort R Jr. Diffuse uveitis and chorioretinal changes after yellow fever vaccination: a re-emerging epidemic. Int J Retina Vitreous. 2019;5:30. doi:https://doi.org/10.1186/s40942-019-0180-0.
- Ng CC, Jumper JM, Cunningham ET Jr. Multiple evanescent white dot syndrome following influenza immunization - A multimodal imaging study. Am J Ophthalmol Case Rep. Sep, 2020;19:100845. doi:https://doi.org/10.1016/j.ajoc.2020.100845.
- Jorge LF, Queiroz RP, Gasparin F, Vasconcelos-Santos DV. Presumed unilateral acute idiopathic maculopathy following H1N1 vaccination. Ocul Immunol Inflamm. Mar 11, 2020;1-3. doi:https://doi.org/10.1080/09273948.2020.1734213.
- Shah P, Zaveri JS, Haddock LJ. Acute macular neuroretinopathy following the administration of an influenza vaccination. Ophthalmic Surg Lasers Imaging Retina. Oct 1, 2018;49(10):e165–e168. doi:https://doi.org/10.3928/23258160-20181002-23.
- Sood AB, O’Keefe G, Bui D, Jain N. Vogt-Koyanagi-Harada disease associated with hepatitis B vaccination. Ocul Immunol Inflamm. 2019;27(4):524–527. doi:https://doi.org/10.1080/09273948.2018.1483520.
- Abou-Samra A, Tarabishy AB. Multiple evanescent white dot syndrome following intradermal influenza vaccination. Ocul Immunol Inflamm. 2019;27(4):528–530. doi:https://doi.org/10.1080/09273948.2017.1423334.
- Biancardi AL, Moraes HV Jr. Anterior and intermediate uveitis following yellow fever vaccination with fractional dose: case reports. Ocul Immunol Inflamm. 2019;27(4):521–523. doi:https://doi.org/10.1080/09273948.2018.1510529.
- Aggarwal K, Agarwal A, Jaiswal N, et al. Ocular surface manifestations of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. PLoS One. Nov 5, 2020;15(11):e0241661. doi:https://doi.org/10.1371/journal.pone.0241661.
- Lim LW, Tan GS, Yong V, et al. Acute onset of bilateral follicular conjunctivitis in two patients with confirmed SARS-CoV-2 infections. Ocul Immunol Inflamm. Nov 16, 2020;28(8):1280–1284. Epub 2020 Oct 6. PMID: 33021847. doi:https://doi.org/10.1080/09273948.2020.1821901.
- Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. Apr 2, 2020;28(3):391–395. Epub 2020 Mar 16. doi:https://doi.org/10.1080/09273948.2020.1738501.
- Elenga N, Martin E, Gerard M, Osei L, Rasouly N. Unilateral diplopia and ptosis in a child with COVID-19 revealing third cranial nerve palsy. J Infect Public Health. Aug 10, 2021;14(9):1198–1200. Epub ahead of print. doi:https://doi.org/10.1016/j.jiph.2021.08.007.
- Umapathi T, Li KZ, Chin CF, et al. Acute isolated near vision difficulty in patients with COVID-19 infection. J Neuroophthalmol. Sep 1, 2021;41(3):e279–e282. doi:https://doi.org/10.1097/WNO.0000000000001120.
- Sen S, Kannan NB, Kumar J, et al. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review. Int Ophthalmol. Aug 11, 2021;1–14. ( Epub ahead of print. PMID: 34379290; PMCID: PMC8356207). doi:https://doi.org/10.1007/s10792-021-01996-7.
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. Dec 31, 2020;383(27):2603–2615. doi:https://doi.org/10.1056/NEJMoa2034577.
- Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. Feb 4, 2021;384(5):403–416. doi:https://doi.org/10.1056/NEJMoa2035389.
- Heath PT, Galiza EP, Baxter DN, et al. Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N Engl J Med. Jun 30, 2021. doi:https://doi.org/10.1056/NEJMoa2107659.
- Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. Jun 10, 2021;384(23):2187–2201. doi:https://doi.org/10.1056/NEJMoa2101544.
- Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. Jan 9, 2021;397(10269):99–111. doi:https://doi.org/10.1016/s0140-6736(20)32661-1.
- Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. Jul 3, 2020;369(6499):77–81. doi:https://doi.org/10.1126/science.abc1932.
- Xia S, Zhang Y, Wang Y, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. Jan, 2021;21(1):39–51. doi:https://doi.org/10.1016/s1473-3099(20)30831-8.
- Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet. May 1, 2021;397(10285):e11. doi:https://doi.org/10.1016/s0140-6736(21)00872-2.
- Bøhler AD, Strøm ME, Sandvig KU, Moe MC, Jørstad ØK. Acute macular neuroretinopathy following COVID-19 vaccination. Eye (Lond). Jun 22, 2021;1-2. doi:https://doi.org/10.1038/s41433-021-01610-1.
- Book BAJ, Schmidt B, Foerster AMH. Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA Ophthalmol. Jul 1, 2021;139(7):e212471. doi:https://doi.org/10.1001/jamaophthalmol.2021.2471.
- Colella G, Orlandi M, Cirillo N. Bell’s palsy following COVID-19 vaccination. J Neurol. Feb 21, 2021;1-3. doi:https://doi.org/10.1007/s00415-021-10462-4.
- Crnej A, Khoueir Z, Cherfan G, Saad A. Acute corneal endothelial graft rejection following COVID-19 vaccination. J Fr Ophtalmol. Jul 8, 2021. doi:https://doi.org/10.1016/j.jfo.2021.06.001.
- ElSheikh RH, Haseeb A, Eleiwa TK, Elhusseiny AM. Acute uveitis following COVID-19 vaccination. Ocul Immunol Inflamm. Aug 11, 2021;1-3. doi:https://doi.org/10.1080/09273948.2021.1962917.
- Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. Sep, 2021;23:101136. doi:https://doi.org/10.1016/j.ajoc.2021.101136.
- Goyal M, Murthy SI, Annum S. Bilateral multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflamm. Aug 3, 2021;1-5. doi:https://doi.org/10.1080/09273948.2021.1957123.
- Mambretti M, Huemer J, Torregrossa G, Ullrich M, Findl O, Casalino G. Acute macular neuroretinopathy following coronavirus disease 2019 vaccination. Ocul Immunol Inflamm. Jun 30, 2021;1-4. doi:https://doi.org/10.1080/09273948.2021.1946567.
- Michel T, Stolowy N, Gascon P, et al. Acute Macular Neuroretinopathy After COVID-19 Vaccine. J Ophthalmic Inflamm Infect.2021.
- Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocul Immunol Inflamm. Jul 2, 2021;1-2. doi:https://doi.org/10.1080/09273948.2021.1949478.
- Ozonoff A, Nanishi E, Levy O. Bell’s palsy and SARS-CoV-2 vaccines. Lancet Infect Dis. Apr, 2021;21(4):450–452. doi:https://doi.org/10.1016/s1473-3099(21)00076-1.
- Papasavvas I, Herbort CP Jr. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm Infect. Jul 5, 2021;11(1):21. doi:https://doi.org/10.1186/s12348-021-00251-5.
- Phylactou M, Li JO, Larkin DFP. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol. Jul, 2021;105(7):893–896. doi:https://doi.org/10.1136/bjophthalmol-2021-319338.
- Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association. Retina. Aug 2, 2021. doi:https://doi.org/10.1097/iae.0000000000003277.
- Ravichandran S, Natarajan R. Corneal graft rejection after COVID-19 vaccination. Indian J Ophthalmol. Jul, 2021;69(7):1953–1954. doi:https://doi.org/10.4103/ijo.IJO_1028_21.
- Renisi G, Lombardi A, Stanzione M, Invernizzi A, Bandera A, Gori A. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? Int J Infect Dis. Jul 18, 2021;110:95–97. doi:https://doi.org/10.1016/j.ijid.2021.07.035.
- Repajic M, Lai XL, Xu P, Bell’s LA. Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain Behav Immun Health. May, 2021;13:100217. doi:https://doi.org/10.1016/j.bbih.2021.100217.
- Reyes-Capo DP, Stevens SM, Cavuoto KM. Acute abducens nerve palsy following COVID-19 vaccination. J Aapos. May 24, 2021. doi:https://doi.org/10.1016/j.jaapos.2021.05.003.
- Santovito LS, Pinna G. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report. Inflamm Res. Jun 4, 2021;1-3. doi:https://doi.org/10.1007/s00011-021-01476-9.
- Shemer A, Pras E, Einan-Lifshitz A, Dubinsky-Pertzov B, Hecht I. Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngol Head Neck Surg. Aug 1, 2021;147(8):739–743. doi:https://doi.org/10.1001/jamaoto.2021.1259.
- Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Sánchez Valadez TI, Jara LJ. Two cases of graves’ disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid. May 3, 2021. doi:https://doi.org/10.1089/thy.2021.0142.
- Wasser LM, Roditi E, Zadok D, Berkowitz L, Weill Y. Keratoplasty rejection after the BNT162b2 messenger RNA vaccine. Cornea. Aug 1, 2021;40(8):1070–1072. doi:https://doi.org/10.1097/ico.0000000000002761.
- US Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine/ BNT162b2 emergency use authorization review memorandum. Accessed 1 August, 2021. https://www.fda.gov/media/144416/download
- US Food and Drug Administration. Moderna COVID-19 vaccine/mRNA-1273 emergency use authorization review memorandum. Accessed 1 August, 2021. https://www.fda.gov/media/144673/download
- Cirillo N, Doan R. Bell’s palsy and SARS-CoV-2 vaccines-an unfolding story. Lancet Infect Dis. Jun 7, 2021;21:1210–1211. doi:https://doi.org/10.1016/s1473-3099(21)00273-5.
- Erdur H, Ernst S, Ahmadi M, et al. Evidence for seasonal variation of Bell’s Palsy in Germany. Neuroepidemiology. 2018;51(3–4):128–130.doi:https://doi.org/10.1159/000492097.
- Bhavsar KV, Lin S, Rahimy E, et al. Acute macular neuroretinopathy: a comprehensive review of the literature. Surv Ophthalmol. Sep-Oct, 2016;61(5):538–565. doi:https://doi.org/10.1016/j.survophthal.2016.03.003.
- Hwang CK, Sen HN. Concurrent vascular flow defects at the deep capillary plexus and choriocapillaris layers in acute macular neuroretinopathy on multimodal imaging: a case series. Am J Ophthalmol Case Rep. Dec, 2020;20:100866. doi:https://doi.org/10.1016/j.ajoc.2020.100866.
- Madendag Y, Acmaz G, Atas M, et al. The effect of oral contraceptive pills on the macula, the retinal nerve fiber layer, and choroidal thickness. Med Sci Monit. Nov 27, 2017;23:5657–5661. doi:https://doi.org/10.12659/msm.905183.
- Fuchsjäger-Mayrl G, Nepp J, Schneeberger C, et al. Identification of estrogen and progesterone receptor mRNA expression in the conjunctiva of premenopausal women. Invest Ophthalmol Vis Sci. Sep, 2002;43(9):2841–2844.
- Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, Mohammadi P, Nomovi M, Mowla A. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci. Aug 3, 2021;428:117607. doi:https://doi.org/10.1016/j.jns.2021.117607.
- Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. Jun 3, 2021;384(22):2092–2101. doi:https://doi.org/10.1056/NEJMoa2104840.
- Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. Jun 3, 2021;384(22):2124–2130. doi:https://doi.org/10.1056/NEJMoa2104882.
- Perry RJ, Tamborska A, Singh B, et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet. Aug 6, 2021. doi:https://doi.org/10.1016/s0140-6736(21)01608-1.
- See I, Su JR, Lale A, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. Jama. Jun 22, 2021;325(24):2448–2456. doi:https://doi.org/10.1001/jama.2021.7517.
- Schulz JB, Berlit P, Diener HC, et al. COVID-19 vaccine-associated cerebral venous thrombosis in Germany. Ann Neurol. Jul 19, 2021. doi:https://doi.org/10.1002/ana.26172.
- Panovska-Stavridis I, Pivkova-Veljanovska A, Trajkova S, et al. Case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. Mediterr J Hematol Infect Dis. 2021;13(1):e2021048. doi:https://doi.org/10.4084/mjhid.2021.048.
- Tan DT, Dart JK, Holland EJ, Kinoshita S. Corneal transplantation. Lancet. May 5, 2012;379(9827):1749–1761. doi:https://doi.org/10.1016/s0140-6736(12)60437-1.
- Jin SX, Juthani VV. Acute corneal endothelial graft rejection with coinciding COVID-19 infection. Cornea. Jan, 2021;40(1):123–124. doi:https://doi.org/10.1097/ico.0000000000002556.
- Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. Aug 7, 2020;369(6504):718–724. doi:https://doi.org/10.1126/science.abc6027.
- Hamilton A, Massera R, Maloof A. Stromal rejection in a deep anterior lamellar keratoplasty following influenza vaccination. Clin Exp Ophthalmol. Dec, 2015;43(9):838–839. doi:https://doi.org/10.1111/ceo.12560.
- Matoba A. Corneal allograft rejection associated with herpes zoster recombinant adjuvanted vaccine. Cornea. Jun 9, 2021. doi:https://doi.org/10.1097/ico.0000000000002787.
- Vignapiano R, Vicchio L, Favuzza E, Cennamo M, Mencucci R. Corneal graft rejection after yellow fever vaccine: a case report. Ocul Immunol Inflamm. Jan 28, 2021;1-4. doi:https://doi.org/10.1080/09273948.2020.1870146.
- Ramakrishnan MS, Patel AP, Melles R, Vora RA. Multiple evanescent white dot syndrome: findings from a large Northern California Cohort. Ophthalmol Retina. Nov 30, 2020. doi:https://doi.org/10.1016/j.oret.2020.11.016.
- Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y. ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab. Jan, 2020;34(1):101412. doi:https://doi.org/10.1016/j.beem.2020.101412.
- Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel). Apr 29, 2021;9(5). doi:https://doi.org/10.3390/vaccines9050435.
- Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. Apr, 2021;21(4):195–197. doi:https://doi.org/10.1038/s41577-021-00526-x.
- Rodero MP, Crow YJ. Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med. Nov 14, 2016;213(12):2527–2538. doi:https://doi.org/10.1084/jem.20161596.
- Leibowitz JA, Woods AT, Kesselman MM, Mayi BS. Uveitis as a predictor of predisposition to autoimmunity. Cureus. Mar 28, 2020;12(3):e7451. doi:https://doi.org/10.7759/cureus.7451.
- Mailand MT, Frederiksen JL. Vaccines and multiple sclerosis: a systematic review. J Neurol. Jun, 2017;264(6):1035–1050. doi:https://doi.org/10.1007/s00415-016-8263-4.